CD40LG and atherosclerosis: Previously, studies have shown that cardiovascular disease patients with higher anti-oxLDL IgM antibody levels have a reduced atherosclerotic burden and a better prognosis, suggesting that anti-oxLDL antibodies have protective characteristics in atherosclerosis [7,8,9].